Primary Genotypic and Phenotypic HIV‐1 Drug Resistance in Recent Seroconverters in Madrid

No abstract is available for this paper.

• Publication year

  2001

• Venue

  Journal of Acquired Immune Deficiency Syndromes

• Publication date

  2001-02-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1097/00042560-200102010-00006PMID 11242181
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• A Novel Human Immunodeficiency Virus Type 1 Reverse Transcriptase Mutational Pattern Confers Phenotypic Lamivudine Resistance in the Absence of Mutation 184V

  2000cited by this paper
• Prevalence of HIV-1 resistant to antiretroviral drugs in 81 individuals newly infected by sexual contact or injecting drug use

  2000cited by this paper
• Dynamics of dominance of a dipeptide insertion in reverse transcriptase of HIV-1 from patients subjected to prolonged therapy.

  2000cited by this paper
• Antiretroviral drug resistance testing in adult HIV-1 infection: recommendations of an International AIDS Society-USA Panel.

  2000cited by this paper
• Prevalence of genotypic resistance to nucleoside analogues and protease inhibitors in Spain

  2000cited by this paper
• Transmission and Prevalence of HIV Resistance among Treatment-Naive Subjects

  2000cited by this paper
• Reduction in human immunodeficiency virus type 1 mutations associated with drug resistance after initiating new therapeutic regimens in pretreated patients.

  2000cited by this paper
• Prevalence of genotypic and phenotypic resistance to anti-retroviral drugs in a cohort of therapy-naïve HIV-1 infected US military personnel

  2000cited by this paper
• Genotypic analysis of HIV-1 isolates to identify antiretroviral resistance mutations from source patients involved in health care worker occupational exposures.

  1999cited by this paper
• High prevalence of multiple drug resistance mutations in a UK HIV/AIDS patient population.

  1999cited by this paper
• Decreased Processivity of Human Immunodeficiency Virus Type 1 Reverse Transcriptase (RT) Containing Didanosine-Selected Mutation Leu74Val: a Comparative Analysis of RT Variants Leu74Val and Lamivudine-Selected Met184Val

  1999cited by this paper
• Introduction of HIV drug-resistance testing in clinical practice.

  1999cited by this paper
• Reduced antiretroviral drug susceptibility among patients with primary HIV infection.

  1999cited by this paper
• HIV-1 drug resistance in newly infected individuals.

  1999cited by this paper
• Rapid decline in detectability of HIV-1 drug resistance mutations after stopping therapy.

  1999cited by this paper
• Human immunodeficiency virus type 1 expressing the lamivudine-associated M184V mutation in reverse transcriptase shows increased susceptibility to adefovir and decreased replication capability in vitro.

  1999cited by this paper
• Replicative Fitness of Protease Inhibitor-Resistant Mutants of Human Immunodeficiency Virus Type 1

  1999cited by this paper
• Transmission of antiretroviral-drug-resistant HIV-1 variants.

  1999cited by this paper
• Interruption of reverse transcriptase inhibitors or a switch from reverse transcriptase to protease inhibitors resulted in a fast reappearance of virus strains with a reverse transcriptase inhibitor-sensitive genotype.

  1999cited by this paper
• Drug Resistance Patterns, Genetic Subtypes, Clinical Features, and Risk Factors in Military Personnel with HIV-1 Seroconversion

  1999cited by this paper
• Spanish consensus conference on drug resistance testing in clinical practice. HIV drug resistance Spanish panel.

  1999cited by this paper
• Activities of cefepime and five other antibiotics against nosocomial PER-1-type and/or OXA-10-type beta-lactamase-producing Pseudomonas aeruginosa and Acinetobacter spp.

  1998cited by this paper
• A Rapid Method for Simultaneous Detection of Phenotypic Resistance to Inhibitors of Protease and Reverse Transcriptase in Recombinant Human Immunodeficiency Virus Type 1 Isolates from Patients Treated with Antiretroviral Drugs

  1998cited by this paper
• Evolution of Genotypic Resistance to Nucleoside Analogues in Patients Receiving Protease Inhibitor-Containing Regimens

  1998cited by this paper
• Switch to Unusual Amino Acids at Codon 215 of the Human Immunodeficiency Virus Type 1 Reverse Transcriptase Gene in Seroconvertors Infected with Zidovudine-Resistant Variants

  1998cited by this paper
• Public health implications of antiretroviral therapy and HIV drug resistance.

  1998cited by this paper
• Prevalence of genotypic resistance to nucleoside analogues in antiretroviral‐naive and antiretroviral‐experienced HIV‐infected patients in Spain

  1998cited by this paper
• Lack of emergence of genotypic resistance to stavudine after 2 years of monotherapy.

  1997cited by this paper
• Large proportion of non-B HIV-1 subtypes and presence of zidovudine resistance mutations among German seroconvertors.

  1997cited by this paper
• Prevalence of zidovudine-resistant HIV-1 among rapid progressors.

  1996cited by this paper
• The prognostic significance of serum viral load, codon 215 reverse transcriptase mutation and CD4+ T cells on progression of HIV disease in a double-blind study of thymopentin

  1996cited by this paper
• Effects of zidovudine use during pregnancy on resistance and vertical transmission of human immunodeficiency virus type 1.

  1995cited by this paper
• Zidovudine Resistance and HIV-1 Disease Progression during Antiretroviral Therapy

  1995cited by this paper
• CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice.

  1994cited by this paper
• Long-term persistence of zidovudine resistance mutations in plasma isolates of human immunodeficiency virus type 1 of dideoxyinosine-treated patients removed from zidovudine therapy.

  1994cited by this paper

• The Pre-clinical Toolbox of Pharmacokinetics and Pharmacodynamics: in vitro and ex vivo Models

  2019cites this paper
• An international study to characterise recently acquired HIV infection in Estonia, Poland, and Ukraine.

  2015cites this paper
• Trends in Prevalence of HIV‐1 Drug Resistance in Thailand 2009–2010

  2013cites this paper
• Baseline Clinical HIV Genotypes Are a Valid Measure of Transmitted Drug Resistance Within the Treatment-Naive Population

  2013cites this paper
• Mechanism of HIV antiretroviral drugs progress toward drug resistance

  2012cites this paper
• A comparative study of anti retroviral drug resistance profiles in two areas of Sydney , Australia from 1986 – 2003

  2012cites this paper
• Preclinical Evaluation of the HIV-1 Fusion Inhibitor L'644 as a Potential Candidate Microbicide

  2012cites this paper
• Potential use of protease inhibitors as vaginal and colorectal microbicides.

  2012cites this paper
• Genotipagem da resistência genotípica secundária aos antirretrovirais em pacientes com aids nos Estados do Pará e Amazonas, Brasil: 2002 a 2006

  2011cites this paper
• Profile of secondary genotypic resistance to antiretroviral drugs in aids patients in the States of Pará and Amazonas, Brazil: 2002 to 2006

  2011cites this paper
• Colorectal microbicide design: triple combinations of reverse transcriptase inhibitors are optimal against HIV-1 in tissue explants

  2011cites this paper
• Genotypic antiretroviral drug resistance in a cohort of HIV infected drug naïve Ugandan Women

  2010cites this paper
• [Epidemiology of drug-resistant HIV-1 transmission in naïve patients in Spain].

  2010cites this paper
• Viral Genotyping and the Sequencing Revolution

  2010cites this paper
• UNIVERSIDADE FEDERAL DE GOIÁS PROGRAMA DE PÓS-GRADUAÇÃO EM MEDICINA TROPICAL

  2010cites this paper
• Brazilian Network for HIV Drug Resistance Surveillance: a survey of individuals recently diagnosed with HIV

  2009cites this paper
• Primary Anti-retroviral Resistance in Treatment-naive HIV-infected Patients: A Korean HIV/AIDS Cohort Study

  2009cites this paper
• Reverse Transcriptase Inhibitors as Potential Colorectal Microbicides

  2009cites this paper
• Monitoring HIV drug resistance in treatment-naive individuals: molecular indicators, epidemiology and clinical implications.

  2009cites this paper
• PrimaryAnti-retroviralResistanceinTreatment-naiveHIV-infectedPatients: AKoreanHIV/AIDSCohortStudy

  2009cites this paper
• Genotipagem para resistência primária e secundária em pacientes infectadospelo HIV-1 do estado de Goiás

  2009cites this paper
• Prevalence of transmitted HIV-1 drug resistance in HIV-1-infected patients in Italy: evolution over 12 years and predictors.

  2009cites this paper
• [Prevalence of primary resistance mutations in patients with newly diagnosed HIV infection in the province of Málaga (Spain)].

  2008cites this paper
• Prevalence of Primary Antiretroviral Resistance: Trends in Korea

  2008cites this paper
• Sexual networks and the transmission of drug-resistant HIV

  2008cites this paper
• Antiretroviral drug resistance among antiretroviral‐naïve persons with recent HIV infection in Thailand

  2008cites this paper
• Prevalencia de mutaciones de resistencia primaria en los nuevos diagnósticos de infección por el VIH en la provincia de Málaga

  2008influential citation
• Integrating multidimensional HIV prevention programs into healthcare settings.

  2008cites this paper
• Phylogenetic Investigation of Transmission Pathways of Drug-Resistant HIV-1 Utilizing Pol Sequences Derived From Resistance Genotyping

  2008cites this paper
• Antiretroviral (ARV) drug resistance in the developing world.

  2007cites this paper
• High Levels of Primary Antiretroviral Resistance Genotypic Mutations And B/F Recombinants in Santos, Brazil

  2007cites this paper
• Prevalence of primary genotypic resistance in a UK centre: comparison of primary HIV-1 and newly diagnosed treatment-naive individuals

  2007cites this paper
• Impact of transmission of drug‐resistant HIV on the course of infection and the treatment success. Data from the German HIV‐1 Seroconverter Study

  2007cites this paper
• Human immunodeficiency virus‐1 subtypes and antiretroviral drug resistance profiles among drug‐naïve Brazilian blood donors

  2007cites this paper
• Human immunodeficiency virus type 1 protease and reverse transcriptase mutation patterns among treatment‐naive patients in different stages of infection in Rio de Janeiro, Brazil

  2007cites this paper
• HIV Drug-resistant Strains as Epidemiologic Sentinels

  2006cites this paper
• Comentarios finales: es tiempo de cumplir

  2006cites this paper
• Prevalence of Drug-Resistance Mutations and Non-Subtype B Strains Among HIV-Infected Infants From New York State

  2006cites this paper
• Transmitted drug‐resistant HIV‐1 in primary HIV‐1 infection; incidence, evolution and impact on response to antiretroviral therapy

  2006cites this paper
• New Reverse Transcriptase Inhibitors in Development

  2006cites this paper
• A Population-Based Approach to Determine the Prevalence of Transmitted Drug-Resistant HIV Among Recent Versus Established HIV Infections: Results From the Canadian HIV Strain and Drug Resistance Surveillance Program

  2006influential citation
• Access to highly active antiretroviral therapy for injection drug users: adherence, resistance, and death.

  2006cites this paper
• HIV-1 Subtype C Drug-Resistance Background among ARV-Naive Adults in Botswana

  2005cites this paper
• Resistência primária do HIV-1 em pacientes atendidos no serviço de referência HIV / AIDS do Hospital das Clínicas da UFPE

  2005cites this paper
• Resistance to nonnucleoside reverse-transcriptase inhibitors and prevalence of HIV type 1 non-B subtypes are increasing among persons with recent infection in Spain.

  2005cites this paper
• Prevalence of antiretroviral drug resistance mutations in chronically HIV-infected, treatment-naive patients: implications for routine resistance screening before initiation of antiretroviral therapy.

  2005cites this paper
• Retrovirus Reverse Transcriptases Containing a Modified YXDD Motif

  2005cites this paper
• The antiretroviral rollout and drug-resistant HIV in Africa: insights from empirical data and theoretical models.

  2005cites this paper
• Molecular characteristics of HIV type 1 circulating in São Paulo, Brazil.

  2005cites this paper
• Antiretroviral recommendations may influence the rate of transmission of drug-resistant HIV type 1.

  2005cites this paper
• Prospects for the resistance to HIV protease inhibitors: current drug design approaches and perspectives.

  2005cites this paper
• Resistance testing in drug-naive HIV-infected patients: is it time?

  2005cites this paper
• The global status of resistance to antiretroviral drugs.

  2005cites this paper
• High resistance to antiretroviral drugs: the Indian experience

  2004cites this paper
• Novel patterns of nevirapine resistance-associated mutations of human immunodeficiency virus type 1 in treatment-naïve patients.

  2004cites this paper
• Transmission of HIV-1 drug resistance.

  2004influential citation
• [Genotypic resistance of human immunodeficiency virus type 1 in patients with therapeutic failure].

  2004cites this paper
• Prevalence of Human Immunodeficiency Virus Drug Resistance Mutations and Subtypes in Drug-Naive, Infected Individuals in the Army Health Service of Rio de Janeiro, Brazil

  2004cites this paper
• High-Risk Behavior and Potential Transmission of Drug-Resistant HIV Among Injection Drug Users

  2004cites this paper
• Prevalence of Genotypic Resistance to Nucleoside Analogues and Protease Inhibitors in Antiretroviral-Naive HIV Patients in Campania, Italy

  2004cites this paper
• [Advances in the diagnosis and treatment of acute human immunodeficiency virus type 1 (HIV-1) infection].

  2004cites this paper
• Resistencia genotípica del virus de la inmunodeficiencia humana tipo 1 en pacientes con fracaso terapéutico

  2004cites this paper
• Current Patterns in the Epidemiology of Primary HIV Drug Resistance in North America and Europe

  2004cites this paper
• European guidelines for the clinical management and treatment of HIV-infected adults in Europe.

  2003cites this paper
• Antiretroviral drug resistance testing in adults infected with human immunodeficiency virus type 1: 2003 recommendations of an International AIDS Society-USA Panel.

  2003cites this paper
• No increase in protease resistance and a decrease in reverse transcriptase resistance mutations in primary HIV-1 infection: 1992-2001.

  2003cites this paper
• Identification of a Transmission Chain of HIV Type 1 Containing Drug Resistance-Associated Mutations

  2003cites this paper
• Limited Transmission of Drug-Resistant HIV Type 1 in 100 Swedish Newly Detected and Drug-Naive Patients Infected with Subtypes A, B, C, D, G, U, and CRF01_AE

  2003cites this paper
• Genotype, Phenotype, and Virtual Phenotype: Who Needs What and Why?

  2003cites this paper
• Brazilian Network for HIV Drug Resistance Surveillance (HIV-BResNet): a survey of chronically infected individuals

  2003cites this paper
• Rates of transmission of antiretroviral drug resistant strains of HIV-1.

  2003cites this paper
• I. Rationale for HIV-1 drug resistance testing II. Evolution of HIV-1 drug resistance III. Identifying and characterizing drug resistance mutations IV. Protease inhibitor (PI) resistance V Nucleoside/nucleotide RT inhibitor (NRTI) resistance VI Nonnucleoside RT inhibitor (NNRTI) resistance mutations

  2003cites this paper
• in HIV Medicine

  2003cites this paper
• Role of lipid rafts in virus assembly and budding.

  2002cites this paper
• Primary HIV-1 resistance in recently and chronically infected individuals of the Italian Cohort Naive for Antiretrovirals.

  2002cites this paper
• Health care industries’ perspective of viral load assays: the VERSANT HIV-1 RNA 3.0 assay

  2002cites this paper
• Genotypic Testing for Human Immunodeficiency Virus Type 1 Drug Resistance

  2002cites this paper
• [Recommendations for non-occupational postexposure HIV prophylaxis. Spanish Working Group on Non-Occupational Postexposure HIV Prophylaxis of the Catalonian Center for Epidemiological Studies on AIDS and the AIDS Study Group].

  2002cites this paper
• Factors influencing HIV progression in a seroconverter cohort in Madrid from 1985 to 1999

  2002cites this paper
• Evaluation of drug resistance in HIV infection.

  2002cites this paper
• Prevalence of Protease and Reverse Transcriptase Drug Resistance Mutations over Time in Drug-Naïve Human Immunodeficiency Virus Type 1-Positive Individuals in Rio de Janeiro, Brazil

  2002cites this paper
• Recomendaciones para la profilaxis postexposición no ocupacional al VIH

  2002cites this paper
• Decline in the rate of genotypic resistance to antiretroviral drugs in recent HIV seroconverters in Madrid.

  2002cites this paper
• Antiretroviral drug resistance mutations in antiretroviral-naive prisoners.

  2002cites this paper
• Utilidad de los tests para detectar resistencias a los antirretrovirales en la práctica clínica

  2001cites this paper
• In vivo emergence of drug-resistant mutations at less than 50 HIV-1 RNA copies/mL that are maintained at viral rebound in longitudinal plasma samples from human immunodeficiency virus type-1-infected patients on highly active antiretroviral therapy.

  2001cites this paper
• A Guide to HIV-1 Reverse Transcriptase and Protease Sequencing for Drug Resistance Studies.

  2001cites this paper
• Influencia del tratamiento antirretrovírico de gran actividad en la incidencia de las infecciones oportunistas y neoplasias asociadas a la infección por VIH-I y en la mortalidad.

  2001cites this paper
• The Emergence and Epidemiology of Resistance in the Nucleoside-Experienced HIV-Infected Population

  2000cites this paper
• Short Communication Molecular Characteristics of HIV Type 1 Circulating in São Paulo, Brazil

  year unknowncites this paper